Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy
Advances in Radiation Oncology · 2026-10 · 11 (10) · 102141
DOI: 10.1016/j.adro.2026.102141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Radiation Oncology, 2026-10. Verfasst von Jingjing Michele Dougherty und 20 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the local control (LC) outcomes and safety profile of stereotactic proton ablative radiation therapy (SPAR) for spine metastases in a highly selected patient population, with emphasis on reirradiation cases. Methods and Materials: We retrospectively reviewed all patients who received SPAR between June 2015 and October 2019. Treatments were delivered in 1 to 5 fractions with a median of 3 fractions. The median prescription dose was 39 Gy (range, 20-60 Gy) to the high-dose clinical target volume (CTV) and 24 Gy (range, 16-50 Gy) to the low-dose CTV. All treatments were delivered using pencil-beam scanning proton therapy with single-field or multifield optimization. LC was assessed per spine response assessment in neuro-oncology (SPINO) criteria using follow-up imaging. Survival and recurrence outcomes were estimated by the Kaplan-Meier method. Acute and late adverse events (AEs) were graded using the National Cancer Institute Common Terminology Criteria for Adverse Events v5.0.
Results
Forty-two patients (47 lesions) were treated with SPAR, with 66% treated in the reirradiation setting. With a median imaging follow-up of 13 months, 1- and 2-year LC rates were both 74% (95% CI, 58%-91%). Ten lesions progressed locally (8 in-field, 2 marginal), most commonly within the vertebral body. No significant predictors of progression were identified aside from low-dose CTV and D95%. Acute AEs included 9 pain flares and one grade 3 dermatitis. Late AEs included 3 vertebral compression fractures and one grade 3 peripheral neuropathy. No cases of radiation myelopathy were observed.
Conclusions
SPAR provides durable LC with acceptable toxicity in a highly selected patient population. These findings support the feasibility of SPAR in complex or reirradiation cases, though broader applicability may be limited by access to high-precision proton therapy systems.
Autor:innen und Institutionen
- Departments of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida.
- Departments of Radiology, Mayo Clinic, Rochester, Minnesota.
- Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.
- Departments of Neurosurgery, Mayo Clinic, Rochester, Minnesota.
- Department of Radiation Oncology, Duke University, Durham, North Carolina.
Zitieren
APA
Dougherty, J. M., Kowalchuk, R. O., Ebner, D. K., Merrell, K. W., Johnson-Tesch, B. A., Morris, J. M., Harmsen, W. S., Breen, W. G., Shiraishi, S., Iott, M. J., Stish, B. J., Owen, D., Kruse, J. J., Beltran, C. J., Mikula, A. L., Brown, P. D., Laack, N. N., Foote, R. L., Olivier, K. R., …, & Park, S. S. (2026). Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy. Advances in Radiation Oncology, 11(10), 102141. https://doi.org/10.1016/j.adro.2026.102141
Vancouver
Dougherty JM, Kowalchuk RO, Ebner DK, Merrell KW, Johnson-Tesch BA, Morris JM, et al. Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy. Advances in Radiation Oncology. 2026;11(10):102141. doi:10.1016/j.adro.2026.102141
BibTeX
@article{Dougherty2026,
author = {Dougherty, Jingjing Michele and Kowalchuk, Roman O and Ebner, Daniel K and Merrell, Kenneth W and Johnson-Tesch, Benjamin A and Morris, Jonathan M and Harmsen, William S and Breen, William G and Shiraishi, Satomi and Iott, Matthew J and Stish, Bradley J and Owen, Dawn and Kruse, Jon J and Beltran, Chris J and Mikula, Anthony L and Brown, Paul D and Laack, Nadia N and Foote, Robert L and Olivier, Kenneth R and Mullikin, Trey C and Park, Sean S},
title = {Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy},
journal = {Advances in Radiation Oncology},
year = {2026},
volume = {11},
number = {10},
pages = {102141},
doi = {10.1016/j.adro.2026.102141}
}
EUVIMED